Evidence map›Paper›PMID 29022895›Full record

ArticleCell death & disease2017

Impairment of PTX3 expression in osteoblasts: a key element for osteoporosis.

Manuel Scimeca, Antonietta Salustri, Elena Bonanno, Daniela Nardozi, Cecilia Rao, Eleonora Piccirilli, Maurizio Feola, Virginia Tancredi, Annamaria Rinaldi, Giovanni Iolascon and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The effect of SOX4 gene 3'UTR polymorphisms on osteoporosis.Journal of orthopaedic surgery and research · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Breast-Specific Gamma Imaging with [Journal of clinical medicine · 2020
    Article
  17. Article
  18. Journal of clinical medicine · 2019
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Manuel ScimecaDepartment of Experimental Medicine and Surgery, University "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.
Antonietta SalustriDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.
Elena BonannoDepartment of Experimental Medicine and Surgery, University "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.
Daniela NardoziDepartment of Experimental Medicine and Surgery, University "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.
Cecilia RaoDepartment of Orthopaedics and Traumatology, "Tor Vergata" University of Rome, "Policlinico Tor Vergata" Foundation, Viale Oxford 1, Rome 00133, Italy.
Eleonora PiccirilliDepartment of Orthopaedics and Traumatology, "Tor Vergata" University of Rome, "Policlinico Tor Vergata" Foundation, Viale Oxford 1, Rome 00133, Italy.
Maurizio FeolaDepartment of Orthopaedics and Traumatology, "Tor Vergata" University of Rome, "Policlinico Tor Vergata" Foundation, Viale Oxford 1, Rome 00133, Italy.
Virginia TancrediDepartment of Medicine of Systems, University of Rome Tor Vergata, Via Montpellier 1, Rome, Italy.
Annamaria RinaldiDepartment of Medicine of Systems, University of Rome Tor Vergata, Via Montpellier 1, Rome, Italy.
Giovanni IolasconDepartment of Medical and Surgical Specialties and Dentistry, Second University of Naples, Naples, Italy.
Augusto OrlandiDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.
Elena GasbarraDepartment of Orthopaedics and Traumatology, "Tor Vergata" University of Rome, "Policlinico Tor Vergata" Foundation, Viale Oxford 1, Rome 00133, Italy.
Nicola MaffulliDepartment of Musculoskeletal Disorders, School of Medicine and Surgery, University of Salerno, Salerno, Italy.
Maria Luisa BrandiDepartment of Surgery and Translational Medicine, University of Florence, Florence 50139, Italy.
Umberto TarantinoDepartment of Orthopaedics and Traumatology, "Tor Vergata" University of Rome, "Policlinico Tor Vergata" Foundation, Viale Oxford 1, Rome 00133, Italy.
University of Rome Tor Vergata · ITPoliclinico Tor Vergata · ITMile End Hospital · GBUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pentraxin 3 (PTX3) is a multifunctional glycoprotein regulating inflammatory response, cell proliferation and migration and deposition and remodelling of the extracellular matrix by a variety of cells. In this study, we investigated the possible role of PTX3 in bone homeostasis. To this end, we compared the expression and function of PTX3 in human osteoblasts of osteoporotic, osteoarthritic patients and young subjects not affected by bone diseases. Immunohistochemical analysis performed on bone head biopsies showed a close association between bone health and the number of osteoblasts expressing PTX3. Noteworthy, the proportion of PTX3-positive osteoblasts resulted to be significantly lower in osteoporotic patients compared with both young patients and osteoarthritic patients of the same age. Ex vivo culture of osteoblasts isolated from the three groups of patients confirmed in vivo observation. Specifically, we observed rare runt-related transcription factor 2 (RUNX2) immunopositive osteoblasts expressing PTX3 in cell cultures derived from osteoporotic patients and western blotting analysis showed 80% reduction of PTX3 in the corresponding culture extracts compared with young and osteoarthritic patients. The treatment of human osteoblast primary cultures derived from young patients with anti-PTX3 antibody dramatically affected osteoblast behaviour. Indeed, they lost the morphological and molecular features typical of mature osteoblasts, acquiring fibroblast-like shape and highly decreasing nuclear factor kappa-B ligand (RANKL) and RUNX2 expression. Also, the inhibition of PTX3 negatively affected osteoblast proliferation and their ability to form cell clusters and microhydroxyapatite crystals. Altogether, these results suggest a central role of PTX3 in bone homeostasis showing its involvement in osteoblast proliferation, differentiation and function.

Indexed as

AgedBone and BonesBone DensityCells, CulturedCore Binding Factor Alpha 1 SubunitC-Reactive ProteinFemaleHumansMaleOsteoarthritisOsteoblastsOsteogenesisOsteoporosisPentraxinsRANK LigandSerum Amyloid P-ComponentCore Binding Factor Alpha 1 SubunitC-Reactive ProteinPentraxinsRANK LigandRUNX2 protein, humanSerum Amyloid P-ComponentTNFSF11 protein, human

Identifiers

PMID29022895
PMCPMC5682679
OpenAlexW2763202455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.